Drug Screening

Drug Screening Market  Size, Share, Forecasts Analysis, Company Profiles, Competitive Landscape and Key Regions 2032

As per the Future Market Insights research, the drug screening market is forecasted to advance at a tremendous pace with a CAGR of 16% during the forecast period 2022-2032.

Drug Screening Market to reach US$ 5.3 Bn in 2021 to US$ 18 Bn by 2032 showing an immense improvement

A crucial driver of the drug screening market is the overuse of prescribed drugs and the elevated use of narcotics. According to one of the recent World Drug Reports, drug and alcohol abuse and consumption are on the rise globally.

Drug abuse killed nearly 500,000 people, while drug use disorders resulted in the loss of 18 million years of a healthy life, primarily due to opioids. Similar increases in alcohol consumption have been observed, with the consequences being an increase in the incidence of impaired driving.

The rising consumption of illicit drugs and alcohol will accelerate the development of drug screening products and services on the road, fuelling the drug screening market growth.

Some countries, including South Africa, Colombia, Chile, Argentina, and Canada, consider workplace drug and alcohol testing to violate employee privacy. Such prohibitions in various countries may impede the adoption of drug screening devices etc., thereby limiting the overall market growth.

Several new products, devices, and services have also received regulatory approval and are being adopted by government agencies and corporate organizations and are expected to broaden drug screening market opportunities.

Companies in this market are expected to gain new opportunities as their business strategies shift toward oral swab drug tests and the development of the concept of fingerprint-based drug screening, thereby driving the demand for drug screening devices etc.,

Key Takeaways:

• By product type, the consumables segment is likely to dominate the market since they provide improved solutions to make testing accurate and quick, accelerating market growth.
• As it is a quicker and less invasive sample to collect at the roadside, the oral fluid sample segment is expected to account for a significant drug screening market shareby sample type.
• By drug type, the cannabis/marijuana segment is forecasted to hold sway over the drug testing industrysince marijuana or cannabis is the most commonly used illicit substance in critical markets.
• The drug screening market sizeaccounted for around US$ 5.3 Bn in 2021.

“North America is projected to reign the market owing to the government implementing strict workplace testing regulations as well as expansion strategies followed by players. Furthermore, the region’s high adoption of technologically advanced solutions & favourable reimbursement scenarios has fuelled the market growth.

Key Segments
By Sample Type:

• Urine samples
• Breath Samples
• Oral Fluid Samples
• Hair Samples
• Other Samples

By Product and Service:

• Drug screening
• Analytical Instruments
• Rapid Testing Devices
• Consumables
• Drug Screening Service

By End User:

• Drug Testing Laboratories
• Criminal Justice and Law Enforcement Agencies
• Hospitals
• Drug Treatment Centers
• Individual Users
• Pain Management Centers
• Schools and Colleges
• Workplaces

For More Information: https://www.futuremarketinsights.com/reports/drug-screening-market